Clinical Trial Update: A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing BL-B01D1 to Docetaxel in unresectable locally advanced or metastatic EGFR wild-type non-small cell lung cancer; study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING